For over two thousand years, Chinese emperors prized a bitter, woody mushroom so highly that it was reserved for royalty, and Taoist texts called it the “herb of spiritual potency” — better known today by its folk name, the “mushroom of immortality.” That mushroom is reishi (Ganoderma lucidum), and it is now one of the best-selling medicinal mushrooms on Earth. The question, as always, is whether two millennia of tradition translates into anything a clinical trial can actually measure. The honest answer is mixed: reishi has real, repeatable effects on the immune system and markers of inflammation, and a 2025 meta-analysis of 17 trials found modest but genuine benefits — yet a pair of Cochrane reviews found it does not live up to its reputation for blood sugar, cholesterol, blood pressure, or cancer. Here is what is actually true, and what is still folklore.
📋 Simple Summary
Reishi is a woody medicinal mushroom used in East Asian medicine for over 2,000 years, traditionally taken to promote health and a long life. The honest headline: the best human evidence is for immune support and lower inflammation — studies show it can boost natural killer cells and antioxidant defenses, and a 2025 meta-analysis of 17 randomized trials found modest reductions in BMI, heart rate, and a marker of kidney strain. But the “immortality” reputation does not survive scrutiny: Cochrane reviews found no reliable benefit for blood sugar, cholesterol, blood pressure, or cancer survival. In animals — and even in honey bees — reishi extracts do extend lifespan, but there is no human proof of that. Reishi is generally safe and well tolerated, with the main cautions being a mild blood-thinning effect and rare reports of liver injury. It is a reasonable, evidence-backed immune and wellness supplement — not a longevity miracle.
The detailed breakdown continues below for those who want the full science.
Published: August 16, 2026
Evidence Tier: 🥈 Silver — real human evidence for immune modulation and antioxidant effects, plus a 17-trial meta-analysis with modest benefits, but no proof of the headline longevity or disease-treatment claims
Category: Supplements & Compounds
⚖️ At a Glance: Pros & Cons
⚠️ We are researchers, not doctors. Nothing on this page is medical advice. Talk to your doctor before taking any supplement. The information below is for education only.
✅ Pros (What the Evidence Supports)
- Strongest benefit: Immune modulation in humans — a 12-week trial in 34 advanced cancer patients found reishi polysaccharides increased natural killer (NK) cells and key immune-signaling cytokines (PMID 12916709).
- Antioxidant and modest metabolic support: A 2025 meta-analysis of 17 randomized trials (971 people) found reishi raised the antioxidant enzyme glutathione peroxidase and modestly lowered BMI, creatinine, and heart rate (PMID 40510787).
- Cholesterol benefit (spore oil): A 2025 randomized trial in 110 people with high cholesterol found reishi spore oil lowered total cholesterol, LDL, and triglycerides while raising HDL (PMID 40077714).
- Safety: Well tolerated across decades of trials; most reported side effects are mild and gastrointestinal (PMID 40872598).
❌ Cons (What the Evidence Doesn’t Support or Warns About)
- Biggest limitation: Two Cochrane reviews found no reliable benefit for blood sugar, blood pressure, cholesterol, or cancer survival — the “immortality” and disease-treatment claims are not supported (PMID 25686270, PMID 27045603).
- Lifespan evidence is preclinical: Reishi extended lifespan in honey bees by 16% and shows anti-aging effects in mice, but there is zero human proof of longer life (PMID 41714705).
- Mild blood-thinning effect: Reishi can slow blood clotting, so it interacts with blood thinners and should be stopped before surgery.
- Who should avoid: People on blood thinners, with autoimmune conditions, scheduled for surgery, pregnant or breastfeeding, or with mushroom allergies should consult a doctor first.
What Is Reishi?
Reishi is the common name for Ganoderma lucidum, a woody, shelf-like polypore mushroom that grows on dead or dying hardwood trees across East Asia. Its Chinese name, língzhī, appears in texts dating back over 2,000 years, where it was described as a tonic for vitality, longevity, and “nourishing life” — a reputation that earned it the folk title “mushroom of immortality” (PMID 36734035). It is far too tough and bitter to eat as food, so it is almost always consumed as a tea, tincture, or powdered extract.
The active chemistry falls into two main families:
- Polysaccharides (mainly beta-glucans): Long sugar chains — including β-(1→3),(1→6)-glucans — that are the primary drivers of reishi’s immune effects. They are largely indigestible and act as prebiotics that also bind immune receptors directly (PMID 33876798).
- Triterpenoids (ganoderic acids): Bitter, fat-soluble compounds fairly unique to Ganoderma. More than 150 ganoderic acids have been identified, and they carry most of the anti-inflammatory, liver-protective, and antioxidant activity (PMID 42188043).
One practical point that matters when buying: the part of the mushroom used changes what you get. Fruiting body extracts are richest in triterpenoids; mycelium grown on grain is often diluted with the grain starch it was grown on and is lower in triterpenoids; and spores (especially “cracked” or “wall-broken” spores, and the oil pressed from them) are a concentrated, distinct product used in several of the lipid trials.
How It Works
Reishi acts through several mechanisms that map directly onto how the immune system and metabolism change with age:
- Immune activation via beta-glucans: Beta-glucans bind receptors on immune cells (dectin-1 and toll-like receptors) on macrophages, natural killer (NK) cells, and dendritic cells. This “primes” the immune system — in human studies, reishi polysaccharides increased circulating NK cells and CD56+ cells, and shifted cytokine signaling toward a more responsive immune state (PMID 12916709).
- Anti-inflammatory action via triterpenoids: Ganoderic acids suppress the NF-κB inflammatory pathway — the master switch behind chronic, low-grade “inflammaging” — and reduce pro-inflammatory cytokines like TNF-α and IL-6 (PMID 41599785).
- Antioxidant defense: Reishi raises internal antioxidant enzymes such as glutathione peroxidase and superoxide dismutase rather than just acting as a direct free-radical scavenger, an effect confirmed in the 2025 human meta-analysis (PMID 40510787).
- Gut-microbiota axis: Because the polysaccharides reach the colon undigested, they feed beneficial bacteria and shift the gut flora in ways linked to reduced inflammation and better metabolic health (PMID 42279708).
The Longevity Connection
🛡️ Immunity — the strongest evidence. This is where reishi’s reputation is best backed. In the landmark 2003 Gao trial, 34 advanced-cancer patients took 5.4 grams a day of a reishi polysaccharide extract (Ganopoly) for 12 weeks; their natural killer (NK) cell counts and activity rose significantly, along with IL-2 and interferon-gamma — the cytokines that coordinate an anti-tumor immune response (PMID 12916709). More recently, a 2024 double-blind trial in 60 older women found that 2 grams a day of reishi extract improved lymphocyte immune function, suggesting the immune effect holds in aging populations specifically (PMID 38800991). A systematic review of 34 randomized trials of fungal beta-glucans supports the broader immune picture (PMID 33876798).
🩸 Metabolism — genuinely mixed. The most comprehensive modern look is the 2025 meta-analysis of 17 randomized controlled trials (971 participants): reishi produced modest but statistically significant reductions in BMI (−0.43), creatinine (a kidney-strain marker), and heart rate (−3.92 beats/min), and raised the antioxidant enzyme glutathione peroxidase — but found no meaningful effect on blood sugar or cholesterol (PMID 40510787). Individual trials go both ways: a 2025 trial in 110 people with high cholesterol found reishi spore oil lowered total, LDL, and triglycerides while raising HDL (PMID 40077714), and a 2025 trial in type 2 diabetes found reishi reduced fasting glucose and HbA1c (PMID 41438309). Yet the 2016 Klupp trial — the best-designed study, 84 people with diabetes and metabolic syndrome — found 3 grams a day for 16 weeks changed nothing in HbA1c or fasting glucose (PMID 27511742).
🫀 Heart — no reliable benefit. The 2015 Cochrane review examined reishi for cardiovascular risk factors (5 trials, 398 people) and concluded there was no evidence it improves blood glucose, blood pressure, or blood lipids (PMID 25686270). Combined with the null Klupp trial, the honest read is that reishi is not a heart supplement.
🎗️ Cancer — supportive at best, unproven. A 2016 Cochrane review of reishi for cancer treatment found insufficient evidence that it improves survival or tumor response, though some trials hint it may improve immune markers and quality of life when used alongside conventional treatment (PMID 27045603). Reishi is not a cancer treatment.
🧠 Brain — plausible, preclinical. Reishi polysaccharides appear to protect against age-related cognitive decline in animal models by reshaping the gut microbiome and calming brain inflammation via the gut-brain axis (PMID 41365407), and reishi-derived nanoparticles reduced multi-organ damage in a mouse model of accelerated aging (PMID 41317349). No human trial has yet shown reishi protects the aging brain.
⏳ Lifespan — the “immortality” claim, checked. In the lab, reishi extracts do extend lifespan in model organisms — a 2026 study found reishi increased the lifespan of honey bees by 16.4% (PMID 41714705), and other work shows anti-aging effects in worms, flies, and mice. That is real, but it is a long way from human longevity, and no human study has ever shown reishi extends life.
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| Gao 2003 (PMID 12916709) | Clinical trial (n=34 advanced cancer, 12 wks) | 5.4 g/day polysaccharides increased NK cells, CD56+ cells, IL-2, and interferon-gamma. |
| 2025 meta-analysis (PMID 40510787) | Meta-analysis, 17 RCTs (n=971) | Reduced BMI (−0.43), creatinine, heart rate (−3.92 bpm); raised GPx. No lipid/glucose effect. |
| Klupp 2016 (PMID 27511742) | RCT, double-blind (n=84 T2DM + metabolic syndrome, 16 wks) | 3 g/day had no effect on HbA1c or fasting glucose. |
| Klupp 2015 Cochrane (PMID 25686270) | Cochrane systematic review (5 trials, n=398) | No reliable evidence reishi improves blood glucose, blood pressure, or lipids. |
| 2025 spore oil RCT (PMID 40077714) | RCT, double-blind (n=110 dyslipidemia, 12 wks) | Spore oil lowered total cholesterol, LDL, triglycerides and raised HDL. |
| 2025 T2DM RCT (PMID 41438309) | RCT (type 2 diabetes) | Reishi and kombucha both reduced fasting glucose, 2-h postprandial glucose, and A1C vs control. |
| 2024 older-women RCT (PMID 38800991) | RCT, double-blind (n=60, 8 wks) | 2 g/day improved lymphocyte immune function in older women. |
| Jin 2016 Cochrane (PMID 27045603) | Cochrane systematic review (5 RCTs) | Insufficient evidence reishi improves cancer survival; possible immune/QoL benefit as adjuvant. |
| 2026 bee lifespan (PMID 41714705) | Preclinical (honey bees) | G. lucidum extract increased bee lifespan by 16.4% (p<0.0001). |
Dosing and Safety
Clinical trials have used a wide range — from 500 mg to over 11 grams a day. The most common effective range for a fruiting-body extract is 1,000–3,000 mg per day, split into two doses with food:
| Goal | Dose Used in Trials | Notes |
|---|---|---|
| General immune / wellness support | 1,000–2,000 mg/day extract | The 2024 older-women trial used 2,000 mg/day (PMID 38800991). |
| Antioxidant / metabolic support | 1,500–3,000 mg/day | Meta-analysis range was 200–11,200 mg/day; 3 g/day used in the Klupp trial (PMID 27511742). |
| Cancer-adjuvant protocol (Gao) | 5,400 mg/day (1,800 mg × 3) | Polysaccharide extract; medical supervision only (PMID 12916709). |
| Cholesterol (spore oil) | Spore oil as dosed in trial | 12-week trial in dyslipidemia (PMID 40077714). |
Form selection: Buy a fruiting-body extract (hot water or dual water-and-alcohol) standardized to its polysaccharide content (often 10–30%) and, ideally, triterpenoid/ganoderic-acid content. Mycelium-grown-on-grain products are cheaper but can be diluted with the grain they were grown on, and often contain little of the bitter triterpenoids. Cracked-spore powders and spore oil are a separate, more concentrated product used in the lipid trials. Avoid products with no standardization listed — reishi’s active compounds vary enormously between batches (PMID 42121522).
Safety notes:
- Generally well tolerated. The most common side effects are mild: stomach upset, nausea, dry mouth or throat, dizziness, and occasional skin rash. A 2025 safety review of adaptogenic and immunomodulating natural products (including reishi) found adverse events were mostly mild (PMID 40872598).
- Mild blood-thinning effect. Reishi has weak antiplatelet activity, so it can add to the effect of blood thinners (warfarin, aspirin, clopidogrel) and should be stopped 1–2 weeks before surgery. Tell your doctor if you take anticoagulants.
- May lower blood pressure and blood sugar. Monitor if you take antihypertensives or diabetes medication — reishi could make their effects stronger.
- Rare liver injury reports. Isolated case reports have linked certain powdered reishi extracts to liver injury, typically with unstandardized products. Stop and see a doctor if you develop jaundice, dark urine, or unusual fatigue (PMID 37790044).
- Immune-stimulating: Because reishi activates the immune system, people with autoimmune conditions or organ transplants on immunosuppressants should be cautious and consult a doctor.
- Pregnancy and breastfeeding: Avoid — there is no reliable safety data for concentrated extracts.
- Mushroom allergy: Anyone allergic to mushrooms or fungi should avoid it.
❓ Common Questions About Reishi
What is reishi and how does it work?
Reishi is a woody medicinal mushroom used in East Asian medicine for over 2,000 years, often called the “mushroom of immortality.” Its beta-glucan polysaccharides bind to receptors on immune cells and boost natural killer cells and immune signaling, while its triterpenoid compounds (ganoderic acids) reduce inflammation and act as antioxidants.
What does the evidence actually show?
The evidence is 🥈 Silver overall, and strongest for immune support and lower inflammation: human trials show it boosts natural killer cells and antioxidant enzymes, and a 2025 meta-analysis of 17 trials found modest reductions in BMI, heart rate, and a kidney-strain marker. But Cochrane reviews found no reliable benefit for blood sugar, cholesterol, blood pressure, or cancer, and the lifespan extension shown in animals and bees has never been demonstrated in humans.
What’s the right dose?
Most studies use 1,000 to 3,000 mg per day of a fruiting-body extract, split into two doses with food; the immune studies in older adults used 2,000 mg a day. Look for a product standardized to its polysaccharide (and ideally triterpenoid) content, start at the lower end, and avoid unstandardized powders.
What are the risks and side effects?
Reishi is generally well tolerated; the most common side effects are mild stomach upset, nausea, dry mouth, dizziness, and occasional skin rash. The two things to watch are its mild blood-thinning effect (it can add to blood thinners and should be stopped before surgery) and rare reports of liver injury, usually from unstandardized products.
Who should avoid it?
People on blood thinners, anyone scheduled for surgery, and people with autoimmune conditions or organ transplants should consult a doctor first, because reishi stimulates the immune system and mildly thins the blood. Pregnant or breastfeeding women and anyone with a mushroom allergy should avoid it, and anyone on blood-pressure or diabetes medication should monitor carefully.
The Bottom Line
Reishi is a legitimate immune-support supplement with a 2,000-year reputation that modern trials only partly confirm. The real, repeatable finding is immune modulation: reishi polysaccharides increase natural killer cells and immune-signaling cytokines in humans (PMID 12916709, PMID 38800991), and the 2025 meta-analysis shows it raises antioxidant enzymes while modestly lowering BMI, heart rate, and a kidney-strain marker (PMID 40510787). For a healthy adult looking for an evidence-backed way to support immunity and temper chronic inflammation as they age, reishi is a reasonable choice.
The “mushroom of immortality” framing, however, is not supported. The Cochrane reviews — the gold standard of evidence synthesis — found no reliable benefit for blood sugar, blood pressure, cholesterol, or cancer survival (PMID 25686270, PMID 27045603), and the lifespan extension seen in bees and mice has no human counterpart. Reishi will not make you live longer, cure cancer, or fix your cholesterol, whatever the marketing says.
Our verdict: 🥈 Silver for immune support and general wellness, with a clear-eyed ⚠️ on the longevity and disease-treatment claims. Who it’s for: adults — especially 40+ — who want a safe, well-tolerated way to support immune function and lower background inflammation, and who understand it is a wellness supplement, not a therapy. Who it’s not for: anyone expecting lifespan extension, a cholesterol cure, a blood-sugar fix, or a cancer treatment, or anyone on blood thinners or immunosuppressants without medical guidance. If you take it: a standardized fruiting-body extract, 1,000–2,000 mg a day with food, and skip the “immortality” hype in favor of what the trials actually measured.
Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Reishi is a dietary supplement and is not approved to treat, cure, or prevent any disease. Always consult a qualified healthcare provider before starting any supplement, especially if you take blood thinners or blood-pressure or diabetes medication, have an autoimmune condition or organ transplant, are scheduled for surgery, are allergic to mushrooms, or are pregnant or breastfeeding. Read our full disclaimer →
Sources
- Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003. PMID 12916709
- The Nutritional Significance of Ganoderma lucidum Supplementation on Health-Related Indices: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Food Sci Nutr. 2025. PMID 40510787
- Klupp NL, et al. A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome. Sci Rep. 2016. PMID 27511742
- Klupp N, Chang D, Hawke F, et al. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database Syst Rev. 2015. PMID 25686270
- Clinical Evaluation of Ganoderma lucidum Spore Oil Extract in Individuals with Dyslipidemia. Nutrients. 2025. PMID 40077714
- Comparing the Effects of Ganoderma lucidum and Kombucha Mushrooms on Glycemic Control in Patients with Type 2 Diabetes. Clin Diabetes. 2025. PMID 41438309
- Ganoderma lucidum dry extract food supplement and lymphocyte function of older women. Br J Nutr. 2024. PMID 38800991
- Jin X, Ruiz Beguerie J, Sze DM, Chan GC. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 2016. PMID 27045603
- Fungal extracts influence lifespan and immune responses in the Carniolan honey bee. Sci Rep. 2026. PMID 41714705
- Effects of Ganoderma lucidum Polysaccharide Peptide on Inflammatory and Metabolic Biomarkers in Obese Patients with Cardiometabolic Syndrome: A Randomized Controlled Trial. Curr Drug Discov Technol. 2026. PMID 42312513
- Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum Supplementation on Psychological Stress and Selective Fitness Profile Parameters. Int J Med Mushrooms. 2024. PMID 39241163
- Ganoderma lucidum polysaccharides target the gut-brain axis: unveiling a novel mechanism for ameliorating aging-induced cognitive impairment and oxidative stress. Int J Biol Macromol. 2026. PMID 41365407
- Ganoderma lucidum-derived nanovesicles mitigate multiorgan injury in a doxorubicin-induced acute aging mouse model. Mol Pharm. 2026. PMID 41317349
- Pharmacological Activities and Safety of Ganoderma lucidum Spores: A Systematic Review. Cureus. 2023. PMID 37790044
- Safety Considerations for Natural Products with Adaptogenic and Immunomodulating Activities. Pharmaceuticals. 2025. PMID 40872598
- Effects of fungal beta-glucans on health — a systematic review of randomized controlled trials. Food Funct. 2021. PMID 33876798
- Medicinal Mushroom Supplements in Cancer: A Systematic Review of Clinical Studies. Curr Oncol Rep. 2023. PMID 36995535